MyOme (Biotechnology, Life Sciences) — Funding, Investors & Signals 2026

MyOme

Helping families understand their DNA and how it impacts their health throughout their lives.

Founded 2017

Palo Alto, United States 45 employees Series B Total: $23.00M Biotechnology, Life Sciences

MyOme is a biotechnology startup, founded in 2017, with headquarters in the United States. The company's slogan, "Helping families understand their DNA and how it impacts their health throughout their lives," reflects its core mission. MyOme uses the latest technologies to provide families with secure and portable data, helping them comprehend the implications of their DNA on their lifelong health. The company's recent milestone includes a significant $23.00M Series B investment on 21 June 2022. This investment was secured from a notable group of investors including Founders Fund, Foresite Capital, HOF Capital, SoftBank Group, Healthcare Venture Partners, Natera, and Sequoia Capital. MyOme's commitment to leveraging data science and ML is evident in its call for individuals with expertise in bio stats, data science, and ML to join their passionate team. The company's focus on empowering families with insights into their genetic makeup demonstrates its potential to make a significant impact in the biotechnology space. With strong financial backing from reputable investors, MyOme is poised to continue its growth trajectory and potentially revolutionize how families interact with their genetic information for improved health outcomes.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	••••••	7	•••• ••••	21 Jun 2022
Series B	••••••	1		07 Dec 2021
Series A	••••••	2		23 Oct 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

••••••

•••• ••••

21 Jun 2022

Series B

••••••

07 Dec 2021

Series A

••••••

23 Oct 2019

FAQ About MyOme

Helping families understand their DNA and how it impacts their health throughout their lives.

MyOme was founded in 2017.

MyOme is headquartered in Palo Alto, United States.

MyOme operates in the following industries: Biotechnology, Life Sciences.

MyOme has approximately 45 employees.

MyOme has completed 3 funding rounds, raising a total of $23.00M. The latest funding stage is Series B.

Top alternatives and competitors to MyOme include The Gene Box, Expanse Bioinformatics, Inc. , Genomelink, Ennov1, Sequencing. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

MyOme and The Gene Box are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

MyOme

General Information

Track MyOme

Discover More

About MyOme

Funding Rounds & Investors (3)

MyOme Alternatives & Competitors

FAQ About MyOme

Don't just browse. Track.